1. Home
  2. RVYL vs SPRC Comparison

RVYL vs SPRC Comparison

Compare RVYL & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVYL
  • SPRC
  • Stock Information
  • Founded
  • RVYL 2007
  • SPRC 2004
  • Country
  • RVYL United States
  • SPRC Israel
  • Employees
  • RVYL N/A
  • SPRC N/A
  • Industry
  • RVYL Professional Services
  • SPRC Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVYL Consumer Discretionary
  • SPRC Health Care
  • Exchange
  • RVYL Nasdaq
  • SPRC Nasdaq
  • Market Cap
  • RVYL 10.4M
  • SPRC 11.6M
  • IPO Year
  • RVYL N/A
  • SPRC N/A
  • Fundamental
  • Price
  • RVYL $1.40
  • SPRC $0.60
  • Analyst Decision
  • RVYL Hold
  • SPRC
  • Analyst Count
  • RVYL 1
  • SPRC 0
  • Target Price
  • RVYL N/A
  • SPRC N/A
  • AVG Volume (30 Days)
  • RVYL 101.1K
  • SPRC 24.5M
  • Earning Date
  • RVYL 11-14-2024
  • SPRC 02-15-2025
  • Dividend Yield
  • RVYL N/A
  • SPRC N/A
  • EPS Growth
  • RVYL N/A
  • SPRC N/A
  • EPS
  • RVYL N/A
  • SPRC N/A
  • Revenue
  • RVYL $63,529,000.00
  • SPRC $1,747,000.00
  • Revenue This Year
  • RVYL N/A
  • SPRC N/A
  • Revenue Next Year
  • RVYL $48.92
  • SPRC N/A
  • P/E Ratio
  • RVYL N/A
  • SPRC N/A
  • Revenue Growth
  • RVYL 16.09
  • SPRC N/A
  • 52 Week Low
  • RVYL $0.89
  • SPRC $0.20
  • 52 Week High
  • RVYL $4.85
  • SPRC $6.78
  • Technical
  • Relative Strength Index (RSI)
  • RVYL 49.24
  • SPRC 52.60
  • Support Level
  • RVYL $1.30
  • SPRC $0.63
  • Resistance Level
  • RVYL $1.44
  • SPRC $0.91
  • Average True Range (ATR)
  • RVYL 0.15
  • SPRC 0.22
  • MACD
  • RVYL -0.00
  • SPRC -0.00
  • Stochastic Oscillator
  • RVYL 19.35
  • SPRC 16.95

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: